Nab-paclitaxel: a bright new SPARC in taxane therapy of cancer (editorial) | NOVA. The University of Newcastle's Digital Repository

Home

Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.13/806547

Title: Nab-paclitaxel: a bright new SPARC in taxane therapy of cancer (editorial)
Author/Creator: Ackland, Stephen P.; Bull, James M.; Boyle, Frances M.
Institution: The University of Newcastle. Faculty of Health, School of Health Sciences
Description: A paper in this issue exemplifies two issues that deserve consideration in the clinical research and practice of oncology: 1) adverse events that occur in response to anticancer therapy may be due to excipients rather than the active agent, and the use of a different formulation may be effective; 2) differences in pharmacology and metabolism need to be considered whenever a drug is applied in different ethnic groups.
Relation: Asia-Pacific Journal of Clinical Oncology Vol. 5, Issue 3, p. 147-150
Publisher Link: http://dx.doi.org/10.1111/j.1743-7563.2009.01233.x
Date: 2009
Publisher: Wiley-Blackwell Publishing
Keyword(s): nab-paclitaxel; taxane therapy; cancer medicine; secreted protein acidic and rich in cysteine; oncology
Resource Type: journal article
Identifier: http://hdl.handle.net/1959.13/806547
Identifier: ISSN:1743-7555

97 Visitors

104 Hits

NOVA. The University of Newcastle's Digital Repository